DNASE1 and acute respiratory distress syndrome: Finally, on the therapeutic side, targeting NETs to alleviate the development of ARDS has been shown to be a viable measure, and DNase I, which has the effect of clearing DNA, a key component in NETs, has been approved for clinical treatment.